The endogenous anti-tumor protein TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) was previously investigated as a therapeutic target in oncology due to its ability to activate death receptors in tumor cells, leading to apoptosis [1, 2]. This evidence concerns the gene TNFSF10 and neoplasm.